127 related articles for article (PubMed ID: 3019652)
1. Relationship between potency of blocking type thyrotropin-binding inhibitor immunoglobulin in three women with primary myxedema and thyroid function of their neonates.
Inomata H; Sasaki N; Tamaru K; Ushiku H; Niimi H; Nakajima H
Endocrinol Jpn; 1986 Jun; 33(3):353-9. PubMed ID: 3019652
[TBL] [Abstract][Full Text] [Related]
2. Role of blocking TSH receptor antibodies on the development of hypothyroidism and thyroid atrophy in primary myxedema.
Cho BY; Shong YK; Lee HK; Koh CS; Min HK; Sohn I
Korean J Intern Med; 1989 Jul; 4(2):108-17. PubMed ID: 2577255
[TBL] [Abstract][Full Text] [Related]
3. Maternal thyroid-blocking immunoglobulins in congenital hypothyroidism.
Brown RS; Keating P; Mitchell E
J Clin Endocrinol Metab; 1990 May; 70(5):1341-6. PubMed ID: 2335576
[TBL] [Abstract][Full Text] [Related]
4. Transient neonatal hypothyroidism due to transplacental transfer of maternal immunoglobulins that inhibit TSH binding, TSH-induced cAMP increase and cell growth.
Cho BY; Shong YK; Lee HK; Koh CS; Min HK; Lee M
Endocrinol Jpn; 1988 Dec; 35(6):819-26. PubMed ID: 2907987
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of thyrotropin-stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema: comparison with activities of thyrotropin-binding inhibitor immunoglobulins.
Cho BY; Shong YK; Lee HK; Koh CS; Min HK
Acta Endocrinol (Copenh); 1989 Jan; 120(1):99-106. PubMed ID: 2563181
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
7. Detection and characterization of autoantibodies blocking the TSH-dependent cAMP production using FRTL-5 cells.
Chiovato L; Vitti P; Lombardi A; Lopez G; Santini F; Macchia E; Fenzi GF; Mammoli C; Battiato S; Pinchera A
J Endocrinol Invest; 1987 Aug; 10(4):383-8. PubMed ID: 2824596
[TBL] [Abstract][Full Text] [Related]
8. Detection of thyrotropin binding inhibitory activity in neonatal blood spots.
Brown RS; Bellisario RL; Mitchell E; Keating P; Botero D
J Clin Endocrinol Metab; 1993 Oct; 77(4):1005-8. PubMed ID: 8104953
[TBL] [Abstract][Full Text] [Related]
9. Effective method for prediction of transient hypothyroidism in neonates born to mothers with chronic thyroiditis.
Tamaki H; Amino N; Aozasa M; Mori M; Iwatani Y; Tachi J; Nose O; Tanizawa O; Miyai K
Am J Perinatol; 1989 Jul; 6(3):296-303. PubMed ID: 2567172
[TBL] [Abstract][Full Text] [Related]
10. Transient neonatal 'athyreosis' resulting from thyrotropin-binding inhibitory immunoglobulins.
Connors MH; Styne DM
Pediatrics; 1986 Aug; 78(2):287-90. PubMed ID: 2874542
[TBL] [Abstract][Full Text] [Related]
11. Primary myxedema with thyrotrophin-binding inhibitor immunoglobulins. Clinical and laboratory findings in 15 patients.
Konishi J; Iida Y; Kasagi K; Misaki T; Nakashima T; Endo K; Mori T; Shinpo S; Nohara Y; Matsuura N
Ann Intern Med; 1985 Jul; 103(1):26-31. PubMed ID: 2860835
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of thyrotropin-induced adenosine 3'5'-monophosphate increase by immunoglobulins from patients with primary myxedema.
Konishi J; Iida Y; Endo K; Misaki T; Nohara Y; Matsuura N; Mori T; Torizuka K
J Clin Endocrinol Metab; 1983 Sep; 57(3):544-9. PubMed ID: 6135705
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of monoclonal antithyrotropin receptor antibodies obtained from peripheral lymphocytes of hypothyroid patients with primary myxedema.
Okuda J; Akamizu T; Sugawa H; Matsuda F; Hua L; Mori T
J Clin Endocrinol Metab; 1994 Dec; 79(6):1600-4. PubMed ID: 7989462
[TBL] [Abstract][Full Text] [Related]
14. A case of transient hypothyroidism: sequential serum measurements of autoantibodies inhibiting thyrotropin-stimulated thyroid cAMP production in a neonate.
Rakover Y; Sadeh O; Sobel E; Shneyour A; Kraiem Z
Acta Endocrinol (Copenh); 1990 Jul; 123(1):118-22. PubMed ID: 2167599
[TBL] [Abstract][Full Text] [Related]
15. Sequential serum measurements of thyrotropin binding inhibitor immunoglobulin G in transient familial neonatal hypothyroidism.
Iseki M; Shimizu M; Oikawa T; Hojo H; Arikawa K; Ichikawa Y; Momotani N; Ito K
J Clin Endocrinol Metab; 1983 Aug; 57(2):384-7. PubMed ID: 6134748
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of thyrotropin-induced growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema.
Iida Y; Konishi J; Kasagi K; Misaki T; Arai K; Tokuda Y; Torizuka K
J Clin Endocrinol Metab; 1987 Jan; 64(1):124-30. PubMed ID: 3023425
[TBL] [Abstract][Full Text] [Related]
17. [Idiopathic myxedema and blocking type antibodies to TSH receptor].
Mitsuma T
Nihon Rinsho; 1999 Aug; 57(8):1759-63. PubMed ID: 10483246
[TBL] [Abstract][Full Text] [Related]
18. A predicted case with neonatal transient hypothyroidism due to blocking type thyrotropin binding inhibitor immunoglobulins (TBII).
Ishihara T; Waseda N; Ikekubo K; Kuroda K; Akamizu T; Mori T
Endocrinol Jpn; 1985 Feb; 32(1):189-94. PubMed ID: 2990883
[TBL] [Abstract][Full Text] [Related]
19. Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy.
Kung AW; Lau KS; Kohn LD
Thyroid; 2000 Oct; 10(10):909-17. PubMed ID: 11081257
[TBL] [Abstract][Full Text] [Related]
20. Differences in the levels of TSH-binding inhibitor immunoglobulins in goitrous and agoitrous autoimmune thyroiditis after twelve months of L-thyroxine therapy.
Khoo DH; Eng PH; Ho SC; Fok AC
Clin Endocrinol (Oxf); 1999 Jul; 51(1):73-9. PubMed ID: 10468968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
